Last reviewed · How we verify
NCT07464301
Stress Autism Mate (SAM) App for Stress Management in Adults With Borderline Personality Disorder Traits
NA trial testing Mobile Application for Stress Monitoring and Coping in Borderline Personality Disorder in 16 participants. Completed in 12 November 2024.
15 October 2024
Quick facts
| Lead sponsor | GGZ Centraal |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 16 |
| Start date | 16 April 2024 |
| Primary completion | 15 October 2024 |
| Estimated completion | 12 November 2024 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Mobile Application for Stress Monitoring and Coping
Conditions studied
- Borderline Personality Disorder — all drugs for Borderline Personality Disorder →
- Stress (Psychology) — all drugs for Stress (Psychology) →
- Perceived Stress — all drugs for Perceived Stress →
Sponsor
GGZ Centraal
Who can join
18 and older, any sex, with Borderline Personality Disorder or Stress (Psychology). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this intervention study is to learn whether a stress management app (Stress Autism Mate, SAM) can help reduce stress and support coping in adults with borderline personality disorder traits receiving outpatient mental health care. The SAM app is a self-monitoring app designed in co-creation with and for individuals with autism, that supports users in recognizing, understanding, and managing daily stress. The app measures stress levels multiple times per day by asking what you were doing, how you were feeling and your stress signals. It offers real-time feedback and a visual overview of stress levels at both the daily and weekly level, and connecting to your activities. This allows users to recognize their own stress triggers and patterns. In addition, the app provides practical stress-reducing tips. The study focuses on changes in daily stress levels and self-reported perceived stress, coping self-efficacy, and resilience during and after use of the app. The main questions this study aims to answer are: 1. Does using the SAM app change daily stress levels measured within the app during four weeks of use? 2. Does app use reduce perceived stress and improve coping self-efficacy and resilience after the intervention? Participants will: * Use the SAM app on their smartphone for four weeks * Complete short in-app stress questionnaires multiple times per day * Complete online questionnaires about stress, coping, and resilience at several time points * Continue their regular outpatient treatment during the study
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07464301
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Borderline Personality Disorder
Currently open trials in the same condition.
- NCT06458933 — Testing Interventions for Borderline Personality Disorder. · Phase 2 · recruiting
- NCT07001475 — A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperact · Phase 1 · recruiting
- NCT07119541 — Testing an Alliance-Focused Dialectical Behaviour Therapy Training for Borderline Personality Disorder · NA · active not recruiting
- NCT06446765 — Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder · Phase 2 · recruiting
- NCT07197502 — Treatment of Borderline Personality Disorder With rTMS · NA · recruiting
Other GGZ Centraal trials
Trials by the same sponsor.
- NCT05600205 — Evaluation of Combined Support for the Ambulatory Lifestyle Intervention · NA · unknown
- NCT04922749 — Evaluation of a Multidisciplinary Lifestyle Treatment for Inpatients With Mental Illness · NA · unknown
- NCT03929081 — Alternative Treatment to Reduce Chronicity in OCD: Research Into Brain Response and Adequacy of Treatment · NA · completed
- NCT03157557 — Multidisciplinary Lifestyle-enhancing Treatment for People With Severe Mental Illness in Sheltered Housing Facilities · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07464301 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GGZ Centraal
- Last refreshed: 11 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07464301.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing